INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $25,000 | +56.2% | 12,250 | 0.0% | 0.00% | – |
| Q3 2017 | $16,000 | -23.8% | 12,250 | -8.1% | 0.00% | – |
| Q2 2017 | $21,000 | -41.7% | 13,325 | +3.1% | 0.00% | – |
| Q1 2017 | $36,000 | +100.0% | 12,925 | -1.9% | 0.00% | – |
| Q4 2016 | $18,000 | -64.7% | 13,180 | -59.7% | 0.00% | – |
| Q3 2016 | $51,000 | +15.9% | 32,730 | -1.2% | 0.00% | – |
| Q2 2016 | $44,000 | -96.7% | 33,130 | -86.9% | 0.00% | -100.0% |
| Q1 2016 | $1,336,000 | -31.6% | 253,540 | +1.9% | 0.01% | -27.8% |
| Q4 2015 | $1,952,000 | +527.7% | 248,751 | +575.7% | 0.02% | +500.0% |
| Q3 2015 | $311,000 | -41.0% | 36,815 | -23.6% | 0.00% | +200.0% |
| Q2 2015 | $527,000 | – | 48,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |